Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

May 19, 2016

The O’Neill Report is the British Government’s response to tackling the emerging antibiotic resistance crisis. In order to overcome this global threat, all countries must play their part and take action to address the crisis, including funding research and development for new tools—new classes of antibiotics, but also diagnostics and vaccines—while ensuring sustainable and affordable access for those new tools. At the same time, steps need to be taken to conserve existing antibiotics for as long as possible.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

May 06, 2016

Sharonann Lynch, HIV policy advisor at Doctors Without Borders/Médecins Sans Frontières’ (MSF) Access Campaign, made the following statement on the release of the United Nations Secretary General report on HIV/AIDS ahead of the June UN High Level Meeting on HIV—“Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declarations on HIV and AIDS: On the Fast-Track to End the AIDS epidemic.”

April 27, 2016

MSF hands over global petition as volunteers place 2,500 flowers in front of Pfizer’s headquarters in New York, representing the number of kids who die of pneumonia each day.

April 20, 2016

Despite decades of progress in other corners of the world, new report shows failure to adequately diagnose and treat HIV/AIDS in this region.

April 08, 2016

New York/Lusaka, Zambia—The largest cholera vaccination campaign ever began today in Zambia’s capital, Lusaka. International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is working in close collaboration with the Zambian Ministry of Health and the World Health Organization to vaccinate more than half a million people in the next two weeks to curb the outbreak that began in February in the city’s overcrowded township areas.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

March 10, 2016

Judit Rius Sanjuan, Access Campaign manager & legal policy advisor at Doctors Without Borders/Médecins Sans Frontières (MSF), made the following statement after KaloBios Pharmaceuticals obtained bankruptcy court permission to keep pursing a drug that could receive a US Federal Drug Administration Priority Review Voucher (PRV).

Pages